423 related articles for article (PubMed ID: 25581542)
21. A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma.
Fang D; Seisen T; Yang K; Liu P; Fan X; Singla N; Xiong G; Zhang L; Li X; Zhou L
Eur J Surg Oncol; 2016 Nov; 42(11):1625-1635. PubMed ID: 27612412
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
Bagrodia A; Kuehhas FE; Gayed BA; Wood CG; Raman JD; Kapur P; Derweesh IH; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.
Sharma V; Miest TS; Juvet TS; Toussi A; Packiam V; Chamie K; Matin SF; Boorjian SA; Thompson RH; Frank I; Tollefson MK; Potretzke AM
J Urol; 2021 Sep; 206(3):558-567. PubMed ID: 33908802
[TBL] [Abstract][Full Text] [Related]
24. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
[TBL] [Abstract][Full Text] [Related]
25. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
Xylinas E; Kluth L; Passoni N; Trinh QD; Rieken M; Lee RK; Fajkovic H; Novara G; Margulis V; Raman JD; Lotan Y; Rouprêt M; Aziz A; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Walton T; Karakiewicz PI; Montorsi F; Zerbib M; Scherr DS; Shariat SF;
Eur Urol; 2014 Mar; 65(3):650-8. PubMed ID: 24070577
[TBL] [Abstract][Full Text] [Related]
26. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.
Mandalapu RS; Remzi M; de Reijke TM; Margulis V; Palou J; Kapoor A; Yossepowitch O; Coleman J; Traxer O; Anderson JK; Catto J; de la Rosette J; O'Brien T; Zlotta A; Matin SF
World J Urol; 2017 Mar; 35(3):355-365. PubMed ID: 27233780
[TBL] [Abstract][Full Text] [Related]
27. Ureterorenoscopy for upper tract urothelial carcinoma: how often are we missing lesions?
Yamany T; van Batavia J; Ahn J; Shapiro E; Gupta M
Urology; 2015 Feb; 85(2):311-5. PubMed ID: 25623674
[TBL] [Abstract][Full Text] [Related]
28. Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy - a case control study.
Hoffman A; Yossepowitch O; Erlich Y; Holland R; Lifshitz D
BMC Urol; 2014 Dec; 14():97. PubMed ID: 25468319
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
[TBL] [Abstract][Full Text] [Related]
30. The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience.
Motamedinia P; Keheila M; Leavitt DA; Rastinehad AR; Okeke Z; Smith AD
J Endourol; 2016 Mar; 30(3):262-7. PubMed ID: 26630130
[TBL] [Abstract][Full Text] [Related]
31. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
32. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
33. Ureteroscopic Management of Large ≥2 cm Upper Tract Urothelial Carcinoma: A Comprehensive 23-Year Experience.
Scotland KB; Kleinmann N; Cason D; Hubbard L; Tanimoto R; Healy KA; Hubosky SG; Bagley DH
Urology; 2018 Nov; 121():66-73. PubMed ID: 29964129
[TBL] [Abstract][Full Text] [Related]
34. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.
Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G
J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163
[TBL] [Abstract][Full Text] [Related]
35. Successful Kidney-Sparing Systemic Therapy for a High-Risk Ureteral Carcinoma Case.
Yuan P; Li X; Yuan Y; Xu P; Wang H
Urol Int; 2023; 107(9):895-898. PubMed ID: 37748442
[TBL] [Abstract][Full Text] [Related]
36. Conservative nephron-sparing treatment of upper-tract tumors.
Smith P; Mandel J; Raman JD
Curr Urol Rep; 2013 Apr; 14(2):102-8. PubMed ID: 23344683
[TBL] [Abstract][Full Text] [Related]
37. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.
Upfill-Brown A; Lenis AT; Faiena I; Salmasi AH; Johnson DC; Pooli A; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
World J Urol; 2019 Jun; 37(6):1157-1164. PubMed ID: 30267197
[TBL] [Abstract][Full Text] [Related]
38. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
Fernández MI; Shariat SF; Margulis V; Bolenz C; Montorsi F; Suardi N; Remzi M; Wood CG; Roscigno M; Kikuchi E; Oya M; Zigeuner R; Langner C; Weizer A; Lotan Y; Koppie TM; Raman JD; Karakiewicz P; Bensalah K; Schultz M; Bernier P
Urology; 2009 Jan; 73(1):142-6. PubMed ID: 18845322
[TBL] [Abstract][Full Text] [Related]
39. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
40. Thulium-Holmium:YAG Duo Laser in Conservative Upper Tract Urothelial Cancer Treatment: 13 Years Experience from a Tertiary National Referral Center.
Defidio L; Antonucci M; De Dominicis M; Fuchs G; Patel A
J Endourol; 2019 Nov; 33(11):902-908. PubMed ID: 31422699
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
